Integrated Report

Integrated Report 2022 (For the year ended March 31, 2022)

Japanese

By Section

Profile

• From Sumitomo Dainippon Pharma to Sumitomo Pharma（PDF/1,664KB)
• History of Value Creation and Growth（PDF/551KB)
• Corporate Mission / Corporate Culture（PDF/430KB)
• Main Products（PDF/549KB)
• Financial Highlights（PDF/480KB)
• Non-Financial Highlights（PDF/464KB)
• Table of Contents / Editorial Policy（PDF/541KB)

Value Creation Strategies

• Changes in the Environment Surrounding Pharmaceutical Companies（PDF/561KB)
• Opportunities and Risks（PDF/420KB)
• Business Model（PDF/713KB)
• Message from the President（PDF/1,017KB)
• Financial Policy (Message from the President)（PDF/546KB)
• Information Disclosure Based on the TCFD Recommendations (Responses to Climate Change)（PDF/429KB)
• Feature: Fostering "CHANTO," the capability to deliver the highest performance（PDF/664KB)
• Sustainability and Materiality（PDF/490KB)
• Mid-term Business Plan（PDF/425KB)

Practice & Performance

• Mid-term Business Plan 2022（PDF/418KB)
• Basic Policy I Establishment of growth engine（PDF/5,284KB)

• Strategy 1 Enhance innovation base with new approaches to drug discovery
• Strategy 2 Deliver the highest performance of clinical development Message from the Executive Officers
• Strategy 3 Pipeline expansion through strategic investment
• Strategy 4 Regional strategy centering in Japan, North America and China
• Strategy 5 Launch frontier business

• Basic Policy II Building of flexible and efficient organization（PDF/2,873KB)

• Flexible and efficient organization and operations
• Corporate culture and talent to drive innovation
• Message from the Executive Officer in Charge of Human Resources
• Digital transformation

• Environment（PDF/708KB)
• Contribution to Societies（PDF/871KB)

Governance

• Corporate Governance（PDF/2,067KB)

Financial & Corporate Information

• Ten-Year Summary of Selected Financial Data（PDF/431KB)
• Operating Results and Financial Condition, and Business Risks（PDF/457KB)
• Consolidated Financial Statements（PDF/444KB)
• Value Chain Initiatives（PDF/716KB)
• Basic Knowledge of Pharmaceuticals（PDF/426KB)
• Corporate Profile / Shareholder Data（PDF/424KB)
• External Evaluations（PDF/518KB)

• Integrated Report 2021 (For the year ended March 31, 2021)

  Button
  English (178 pages)

  • Full Report (PDF/11,899KB)

• Integrated Report 2020 (For the year ended March 31, 2020)

  Button
  English (158 pages)

  • Full Report (PDF/6654KB)

• Integrated Report 2019 (For the year ended March 31, 2019)

  Button
  English (130 pages)

  • Full Report (PDF/5070KB)

• Integrated Report 2018 (For the year ended March 31, 2018)

  Button
  English (138 pages)

  • Full Report (PDF/8011KB)

• Annual Report 2017 (For the year ended March 31, 2017)

  Button
  English (102 pages)

  • Full Report (PDF/7691KB)

• Annual Report 2016（For the year ended March 31, 2016）

  Button
  English (96 pages)

  • Full Report (PDF/6048KB)

• Annual Report 2015（For the year ended March 31, 2015）

  Button
  English (90 pages)

  • Full Report (PDF/3047KB)

• Annual Report 2014（For the year ended March 31, 2014）

  Button
  English (92 pages)

  • Full Report (PDF/8946KB)

• Annual Report 2013（For the year ended March 31, 2013）

  Button
  English (89 pages)

  • Full Report (PDF/4995KB)

• Annual Report 2012（For the year ended March 31, 2012）

  Button
  English (81 pages)

  • Full Report (PDF/9358 KB)

• Annual Report 2011（For the year ended March 31, 2011）

  Button
  English (75 pages)

  • Full Report (PDF/3191KB)

• Annual Report 2010（For the year ended March 31, 2010）

  Button
  English (79 pages)

  • Full Report (PDF/4232KB)

• Annual Report 2009（For the year ended March 31, 2009）

  Button
  English (53 pages)

  • Full Report (PDF/1068KB)

• Annual Report 2008（For the year ended March 31, 2008）

  Button
  English (55 pages)

  • Full Report (PDF/1944KB)

• Annual Report 2007（For the year ended March 31, 2007）

  Button
  English (53 pages)

  • Full Report (PDF/1020KB)

• Annual Report 2006（For the year ended March 31, 2006）

  Button
  English (53 pages)

  • Full Report (PDF/1168KB)